Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.
Romanzi A, Milosa F, Marcelli G, Critelli RM, Lasagni S, Gigante I, Dituri F, Schepis F, Cadamuro M, Giannelli G, Fabris L, Villa E. Romanzi A, et al. Among authors: lasagni s. Biomedicines. 2023 Dec 30;12(1):87. doi: 10.3390/biomedicines12010087. Biomedicines. 2023. PMID: 38255193 Free PMC article.
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
Ferrari M, Di Marco L, Pivetti A, Paduano S, Vecchi C, Bernabucci V, Critelli RM, Lasagni S, De Maria M, Venturelli D, Pecorari M, Boaretto G, Serpini GF, Romagnoli D, Mantovani R, Ceccherelli GB, Villa E. Ferrari M, et al. Among authors: lasagni s. Emerg Infect Dis. 2023 Jul;29(7):1479-1481. doi: 10.3201/eid2907.221745. Epub 2023 May 30. Emerg Infect Dis. 2023. PMID: 37253276 Free PMC article.
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Villa E, Donghia R, Baldaccini V, Tedesco CC, Shahini E, Cozzolongo R, Ascari S, Pesole PL, Coletta S, Critelli RM, Lasagni S, Schepis F, Semellini F, Giannelli G. Villa E, et al. Among authors: lasagni s. Hepatol Commun. 2023 Sep 15;7(10):e0262. doi: 10.1097/HC9.0000000000000262. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37708455 Free PMC article.
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Di Marco L, Pivetti A, Foschi FG, D'Amico R, Schepis F, Caporali C, Casari F, Lasagni S, Critelli RM, Milosa F, Romanzi A, Marcelli G, De Maria N, Romagnoli D, Catellani B, Scianò F, Magistri P, Colecchia A, Sighinolfi P, Di Benedetto F, Martinez-Chantar ML, Villa E. Di Marco L, et al. Among authors: lasagni s. Liver Transpl. 2023 May 1;29(5):559-563. doi: 10.1097/LVT.0000000000000087. Epub 2023 Feb 8. Liver Transpl. 2023. PMID: 36747351 Free PMC article. No abstract available.
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.
Villa E, Critelli R, Lasagni S, Melegari A, Curatolo A, Celsa C, Romagnoli D, Melegari G, Pivetti A, Di Marco L, Casari F, Arioli D, Turrini F, Zuccaro V, Cassaniti I, Riefolo M, de Santis E, Bernabucci V, Bianchini M, Lei B, De Maria N, Carulli L, Schepis F, Gozzi C, Malaguti S, Del Buono M, Brugioni L, Torricelli P, Trenti T, Pinelli G, Bertellini E, Bruno R, Cammà C, d'Errico A. Villa E, et al. Among authors: lasagni s. Blood Adv. 2021 Feb 9;5(3):662-673. doi: 10.1182/bloodadvances.2020003736. Blood Adv. 2021. PMID: 33560382 Free PMC article.
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.
Lasagni S, Leonardi F, Pivetti A, Di Marco L, Ravaioli F, Serenari M, Gitto S, Critelli RM, Milosa F, Romanzi A, Mancarella S, Dituri F, Riefolo M, Catellani B, Magistri P, Romagnoli D, Celsa C, Enea M, de Maria N, Schepis F, Colecchia A, Cammà C, Cescon M, d'Errico A, di Benedetto F, Giannelli G, Martinez-Chantar ML, Villa E. Lasagni S, et al. Front Oncol. 2022 Sep 8;12:960808. doi: 10.3389/fonc.2022.960808. eCollection 2022. Front Oncol. 2022. PMID: 36158651 Free PMC article.
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.
Critelli RM, Milosa F, Romanzi A, Lasagni S, Marcelli G, Di Marco L, Pivetti A, Schepis F, Romagnoli D, Mancarella S, Dituri F, Martinez-Chantar ML, Giannelli G, Villa E. Critelli RM, et al. Among authors: lasagni s. Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov. Oncol Lett. 2022. PMID: 36276500 Free PMC article.